Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Hair transplants can risk reactivating lichen planopilaris, a scarring hair loss condition.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

Two genes, ERBB4 and ROR1, may cause the unique pigmentation in Lanping black-boned sheep.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

PLLA dermal fillers can cause hair loss, but it can be treated with steroids.

The enzyme PA-PLA1α is important for proper hair follicle development.

Basement membrane changes in lichen planopilaris cause scarring and permanent hair loss.

PPARgamma is crucial for healthy hair follicles, and its loss causes scarring alopecia.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Adipose tissue-derived exosomes may help treat lichen planopilaris and preserve hair.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Platelet-rich plasma therapy effectively treated laser-induced skin lightening.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

More rigorous and diverse research is needed to improve diagnosis and treatment of Lichen Planopilaris.

A new genetic variant in the LIPH gene causes hair growth issues in a Chinese patient.

The Progressive Loss Risk Scale is a system that shows the long-term risks of hair restoration surgery, which can change based on factors like age and transplant area.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

Phospholipase A2 enzymes play key roles in skin health and disease.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Janus kinase inhibitors may help treat lichen planopilaris.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Lichen planopilaris patients are more likely to have hypothyroidism.

A woman's hair loss was correctly diagnosed as Lichen planopilaris after initial misdiagnosis, highlighting the usefulness of trichoscopy in diagnosing hair disorders.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Lichen planopilaris should be considered in diagnosing scarring hair loss in Black women.

PLA particles release their contents differently based on the type of fluorochrome used.